Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension
Clinical trial NCT00705575 · COMPLETED
Trial details
- NCT number
- NCT00705575
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-04-01
- Enrollment
- 688
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.